Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis MEDS

Max Ratio

Dividend Yield

5Y Dividend Growth

0.00 %

Consecutive Years

5Y Average Payout Ratio

Dividend History MEDS

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield
Consecutive Years 0
Forward Annual Dividend – SEK
Consistent Years 0
Dividend CAGR 3Y
Continuous Dividends 0
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.
Financial Score
Dividend Policy i

Sales Growth MEDS

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin MEDS

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income MEDS

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM MEDS

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio MEDS

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Meds Apotek AB MEDS

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Itself MEDS

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 52.56
Forward PE
Enterprise Value Revenue 0.30
Price Sales TTM 0.37
Enterprise Value EBITDA 18.25
Price Book MRQ 2.85

Meds Apotek AB

MEDS
Current price
21.30 SEK +0.8 SEK (+3.90%)
Last closed 20.50 SEK
ISIN unknown
Sector Consumer Cyclical
Industry Internet Retail
Exchange Stockholm Exchange
Capitalization 381 020 503 SEK
Yield for 12 month -63.28 %
1Y
3Y
5Y
10Y
15Y
MEDS
11/21/2021 - 11/28/2021

Advanced Highlights

Current Year

+1 007 161 790 SEK

Last Year

+829 859 455 SEK

Current Quarter

+270 145 208 SEK

Last Quarter

+257 841 820 SEK

Current Year

+278 397 512 SEK

Last Year

+232 168 215 SEK

Current Quarter

+75 043 282 SEK

Last Quarter

+68 764 485 SEK
EBITDA -658 500 SEK
Operating Margin TTM 1.92 %
Price to Earnings 52.56
Return On Assets TTM
PEG Ratio
Return On Equity TTM 7.88 %
Wall Street Target Price 459.68 SEK
Revenue TTM 1 035 224 195 SEK
Book Value 7.20 SEK
Revenue Per Share TTM 57.68 SEK
Dividend Share
Quarterly Revenue Growth YOY 11.60 %
Dividend Yield
Gross Profit TTM 233 646 348 SEK
Earnings per share 0.39 SEK
Diluted Eps TTM 0.39 SEK
Most Recent Quarter I 2026
Quarterly Earnings Growth YOY -12.90 %
Profit Margin 0.73 %
Price to Free Cash Flow TTM -13.72

Technical Indicators MEDS

For 52 Weeks

20.42 SEK 77.06 SEK
50 Day MA 21.77 SEK
Shares Short Prior Month
200 Day MA 37.00 SEK
Short Ratio
Shares Short
Short Percent